EUVIMEDEUVIMED entdecken
Crossref

Impact of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease on mortality

Jung-Hwan Kim, Yaeji Lee, Chung-Mo Nam, Yu-Jin Kwon, Ji-Won Lee

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2025.103965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Jung-Hwan Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. Hauptthemen laut MEDLINE: Cardiometabolic Risk Factors, Cardiovascular Diseases, Metabolic Syndrome, Fatty Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry, Ministry of Agriculture, Food and Rural Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a potential independent risk factor for cardiovascular disease (CVD)-associated and all-cause mortalities as they share common risk factors. We investigated the association between cardiometabolic risk factors for MASLD and CVD-associated and all-cause mortality risks in middle-aged and older Korean adults. METHODS AND RESULTS: We used data from the Korean Genome and Epidemiology Study, a population-based prospective cohort study. Five cardiometabolic risk factors were assessed. MASLD was defined as liver steatosis with a fatty liver index (FLI) ≥60 and at least one cardiometabolic risk factor. The non-MASLD group included individuals with a FLI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiometabolic Risk FactorsCardiovascular DiseasesMetabolic SyndromeFatty LiverNon-alcoholic Fatty Liver DiseaseHumansMaleMiddle AgedFemaleProspective StudiesRepublic of KoreaRisk AssessmentAgedCause of DeathTime FactorsPrognosisBiomarkersRisk Factors

Stichwörter der Autor:innen

All-cause mortalityCardiometabolic risk factorsCardiovascular disease–associated mortalityFatty liver

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.
  • Department of Biostatistics and Computing, Yonsei University, Seoul, 03722, Republic of Korea.
  • Department of Health Informatics and Biostatistics, Graduate School of Public Health, Yonsei University, Seoul, 03722, Republic of Korea.
  • Department of Family Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, 16995, Republic of Korea. Electronic address: digda3@yuhs.ac.
  • Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea; Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, 03722, Republic of Kor…

Förderung

  • National Research Foundation of Korea
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry
  • Ministry of Agriculture, Food and Rural Affairs
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries

Zitieren

APA

Kim, J. H., Lee, Y., Nam, C. M., Kwon, Y. J., & Lee, J. W. (2025). Impact of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease on mortality. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.103965

Vancouver

Kim JH, Lee Y, Nam CM, Kwon YJ, Lee JW. Impact of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease on mortality. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.103965

BibTeX
@article{Kim2025,
  author = {Kim, Jung-Hwan and Lee, Yaeji and Nam, Chung-Mo and Kwon, Yu-Jin and Lee, Ji-Won},
  title = {Impact of cardiometabolic risk factors for metabolic dysfunction-associated steatotic liver disease on mortality},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2025.103965}
}
Kostenlos starten →